These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2250 related articles for article (PubMed ID: 7881635)

  • 1. Enhanced interleukin-2 production in human tumor-infiltrating lymphocytes engineered by 3'-truncated interleukin-2 gene.
    Yamaue H; Kashmiri SV; De Filippi R; Nieroda C; Yannelli JR; Tsang KY; Schlom J
    J Immunother Emphasis Tumor Immunol; 1994 Nov; 16(4):262-74. PubMed ID: 7881635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated interleukin-2 production by tumors induces growth of cytotoxic tumor-infiltrating lymphocytes against human renal cell carcinoma.
    Mulders P; Tso CL; Pang S; Kaboo R; McBride WH; Hinkel A; Gitlitz B; Dannull J; Figlin R; Belldegrun A
    J Immunother; 1998 May; 21(3):170-80. PubMed ID: 9610908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human gene transfer: characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man.
    Kasid A; Morecki S; Aebersold P; Cornetta K; Culver K; Freeman S; Director E; Lotze MT; Blaese RM; Anderson WF
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):473-7. PubMed ID: 2404283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2.
    Heemskerk B; Liu K; Dudley ME; Johnson LA; Kaiser A; Downey S; Zheng Z; Shelton TE; Matsuda K; Robbins PF; Morgan RA; Rosenberg SA
    Hum Gene Ther; 2008 May; 19(5):496-510. PubMed ID: 18444786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth and autologous tumor lysis by tumor-infiltrating lymphocytes from metastatic melanoma expanded in interleukin-2 or interleukin-2 plus interleukin-4.
    Lindgren CG; Thompson JA; Higuchi CM; Fefer A
    J Immunother Emphasis Tumor Immunol; 1993 Nov; 14(4):322-8. PubMed ID: 8280715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transduction of an IL-2 gene into human melanoma-reactive lymphocytes results in their continued growth in the absence of exogenous IL-2 and maintenance of specific antitumor activity.
    Liu K; Rosenberg SA
    J Immunol; 2001 Dec; 167(11):6356-65. PubMed ID: 11714800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional role of IL-2 receptors on tumour-infiltrating lymphocytes.
    Trentin L; Zambello R; Bulian P; Cerutti A; Milani A; Pirone E; Nitti D; Agostini C; Semenzato G
    Br J Cancer; 1994 Jun; 69(6):1046-51. PubMed ID: 8198969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo proliferation of adoptively transferred tumor-infiltrating lymphocytes in mice.
    Wong RA; Alexander RB; Puri RK; Rosenberg SA
    J Immunother (1991); 1991 Apr; 10(2):120-30. PubMed ID: 2043592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma.
    Tian JQ; Wang ZP; Rodriguez R; Fu JS; Lu JZ; Ma BL
    Urology; 2006 May; 67(5):1093-8. PubMed ID: 16635513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response.
    Aebersold P; Hyatt C; Johnson S; Hines K; Korcak L; Sanders M; Lotze M; Topalian S; Yang J; Rosenberg SA
    J Natl Cancer Inst; 1991 Jul; 83(13):932-7. PubMed ID: 2067036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration in interactions between tumor-infiltrating lymphocytes and tumor cells in human melanomas after chemotherapy or immunotherapy.
    Itoh K; Hayakawa K; Salmeron MA; Legha SS; Murray JL; Talpaz M; Balch CM; Parkinson DR; Lee K; Zukiwski AA
    Cancer Immunol Immunother; 1991; 33(4):238-46. PubMed ID: 2059968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2-independent proliferation of human melanoma-reactive T lymphocytes transduced with an exogenous IL-2 gene is stimulation dependent.
    Liu K; Rosenberg SA
    J Immunother; 2003; 26(3):190-201. PubMed ID: 12806273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The promotive effect of interleukin 4 with interleukin 2 in the proliferation of tumor-infiltrating lymphocytes from patients with malignant tumor.
    Tsunoda T; Tanimura H; Yamaue H; Iwahashi M; Tani M; Tamai M; Arii K; Noguchi K
    Biotherapy; 1992; 4(1):9-15. PubMed ID: 1543654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor.
    Trentin L; Zambello R; Bulian P; Cerutti A; Enthammer C; Cassatella M; Nitti D; Lise M; Agostini C; Semenzato G
    Br J Cancer; 1995 Feb; 71(2):240-5. PubMed ID: 7841036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of auto-tumor infiltrating lymphocytes induced by interleukin (IL)-12 with IL-2 on patients of primary hepatic carcinoma].
    Zhang YX; Wang XY; Liu JB; Zhang SQ; Chen YR
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):973-6. PubMed ID: 18756970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro.
    Li Y; Liu S; Hernandez J; Vence L; Hwu P; Radvanyi L
    J Immunol; 2010 Jan; 184(1):452-65. PubMed ID: 19949105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of tumor-infiltrating lymphocytes from human tumors using the T-cell growth factors interleukin-2 and interleukin-4.
    Kawakami Y; Haas GP; Lotze MT
    J Immunother Emphasis Tumor Immunol; 1993 Nov; 14(4):336-47. PubMed ID: 8280717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and comparison of 'standard' and 'young' tumour-infiltrating lymphocytes for adoptive cell therapy at a Danish translational research institution.
    Donia M; Junker N; Ellebaek E; Andersen MH; Straten PT; Svane IM
    Scand J Immunol; 2012 Feb; 75(2):157-67. PubMed ID: 21955245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological properties of melanoma tumor-infiltrating lymphocytes before and after IL-2-based biotherapies.
    Itoh K; Balch CM; Murray JL; Parkinson DR; Markowitz AB; Talpaz M; Lee K; Zukiwski AA; Ross MI; Legha SS
    In Vivo; 1991; 5(6):647-53. PubMed ID: 1810451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal and functional analysis for the augmentation of tumour-infiltrating lymphocytes by interleukin 4.
    Tsunoda T; Tanimura H; Yamaue H; Iwahashi M; Tani M; Noguchi K; Hotta T; Mizobata S; Arii K
    Br J Cancer; 1996 Oct; 74(7):1085-9. PubMed ID: 8855979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 113.